Dopamine cell replacement therapies for Parkinson's - where are we now? With Professor Roger Barker

In this talk at our Research Update Meeting at the Royal Society of Medicine, Professor Roger Barker summarises the history of dopamine cell therapies for Parkinson’s, where we now are with these new stem cell trials and what the future might look like for the Parkinson’s community using such a therapy.

[@mdfakhrulislam131]

Very Good. Ideas

[@zhuzhou]

This is pretty amazing!

[@dmelin]

Very interesting, thank you.

[@gwhiz5109]

Endometrial stem cells are now being recognized as a plentiful, pluripotent, as well as available without ethical restrictions, collected from banked menstrual blood. I hope this unlimited availability of pluripotent stem cells allows a development of replacement therapies for PD and other cellular disorders.

[@user-zv9zq4xv7x]

Exenatide and ambroxol are mentioned during the discussion but there is no follow up. Is there any update?

[@bruce7372]

chronic neurinflammation is part of Parkinson's Disease. Perhaps cyclosporine on its own could be worth a try.

[@roryblake7311]

Thanks for the program. My TH-cam channel explores the microbiome... and the Lymph System that transports neurotransmitters and precursors from the gut to lymph nodes and the Brain.
We are designed as hunter/gatherers. It seems obvious that older sedentary individuals lack the muscle movement necessary to transport lymph ...since it doesn't have a pump like the heart.

[@paultoensing3126]

I think the results should take between 6 and 8 decades, just to be safe.

[@tootalljones77]

Exactly lol

[@cnam1258]

You got that so right. "Safety first !!"

[@roryblake7311]

Thanks. My TH-cam channel is focused on the Microbiome and Lymph system transfer of neurotransmitters to the brain and lymph nodes in PD. Daily Walking seems to aid transport and in clinical trials!

[@ahmedi9407]

Trial pŕogŕam